Cargando…

Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis

BACKGROUND: Natural killer (NK) cells hold great promise in treating diverse hematopoietic and solid tumors. Despite their availability from peripheral blood and cord blood, stem cell-derived NK cells offer an 'off-the-shelf' solution. Hematopoietic stem and progenitor cells (HSPCs) derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Wei, Chen, Xiang, Shen, Xin-Yi, Li, Hua-Yu, Zhang, Feng, Fang, Feng-Qi, Zhang, Xiao-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578005/
https://www.ncbi.nlm.nih.gov/pubmed/37840146
http://dx.doi.org/10.1186/s13287-023-03461-x
_version_ 1785121431625924608
author Wen, Wei
Chen, Xiang
Shen, Xin-Yi
Li, Hua-Yu
Zhang, Feng
Fang, Feng-Qi
Zhang, Xiao-Bing
author_facet Wen, Wei
Chen, Xiang
Shen, Xin-Yi
Li, Hua-Yu
Zhang, Feng
Fang, Feng-Qi
Zhang, Xiao-Bing
author_sort Wen, Wei
collection PubMed
description BACKGROUND: Natural killer (NK) cells hold great promise in treating diverse hematopoietic and solid tumors. Despite their availability from peripheral blood and cord blood, stem cell-derived NK cells offer an 'off-the-shelf' solution. Hematopoietic stem and progenitor cells (HSPCs) derived from cord blood pose no risk to the newborn or mother and are virtually ideal sources for NK cell differentiation. METHODS: We developed a modified protocol to differentiate HSPCs to NK cells under serum-free conditions using defined factors. The HSPC-derived NK (HSC-NK) cells could be expanded in a K562 feeder cell-dependent manner. Furthermore, using lentivirus transduction, chimeric antigen receptor (CAR)-modified HSPCs could be differentiated into NK cells, leading to the establishment of CAR-NK cells. RESULTS: The efficiency of NK cell differentiation from HSPCs was increased through the simple modulation of osmotic pressure by the addition of sodium chloride or glucose. Furthermore, the hyperosmosis-primed HSC-NK cells exhibited enhanced proliferation capacity and maintained normal functional characteristics, including transcriptome and antitumor efficacy. The optimized protocol yielded approximately 1.8 million NK cells from a single CD34-positive cell within a 28-day cycle, which signifies more than a ten-fold increase in efficiency relative to the conventional methods. This optimized protocol was also suitable for generating CAR-NK cells with high yields compared to standard conditions. CONCLUSIONS: The results of this study establish high osmotic pressure as a simple yet powerful adjustment that significantly enhances the efficiency and functionality of HSC-NK cells, including CAR-NK cells. This optimized protocol could lead to cost-effective, high-yield NK cell therapies, potentially revolutionizing cancer immunotherapy strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03461-x.
format Online
Article
Text
id pubmed-10578005
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105780052023-10-17 Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis Wen, Wei Chen, Xiang Shen, Xin-Yi Li, Hua-Yu Zhang, Feng Fang, Feng-Qi Zhang, Xiao-Bing Stem Cell Res Ther Research BACKGROUND: Natural killer (NK) cells hold great promise in treating diverse hematopoietic and solid tumors. Despite their availability from peripheral blood and cord blood, stem cell-derived NK cells offer an 'off-the-shelf' solution. Hematopoietic stem and progenitor cells (HSPCs) derived from cord blood pose no risk to the newborn or mother and are virtually ideal sources for NK cell differentiation. METHODS: We developed a modified protocol to differentiate HSPCs to NK cells under serum-free conditions using defined factors. The HSPC-derived NK (HSC-NK) cells could be expanded in a K562 feeder cell-dependent manner. Furthermore, using lentivirus transduction, chimeric antigen receptor (CAR)-modified HSPCs could be differentiated into NK cells, leading to the establishment of CAR-NK cells. RESULTS: The efficiency of NK cell differentiation from HSPCs was increased through the simple modulation of osmotic pressure by the addition of sodium chloride or glucose. Furthermore, the hyperosmosis-primed HSC-NK cells exhibited enhanced proliferation capacity and maintained normal functional characteristics, including transcriptome and antitumor efficacy. The optimized protocol yielded approximately 1.8 million NK cells from a single CD34-positive cell within a 28-day cycle, which signifies more than a ten-fold increase in efficiency relative to the conventional methods. This optimized protocol was also suitable for generating CAR-NK cells with high yields compared to standard conditions. CONCLUSIONS: The results of this study establish high osmotic pressure as a simple yet powerful adjustment that significantly enhances the efficiency and functionality of HSC-NK cells, including CAR-NK cells. This optimized protocol could lead to cost-effective, high-yield NK cell therapies, potentially revolutionizing cancer immunotherapy strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03461-x. BioMed Central 2023-10-15 /pmc/articles/PMC10578005/ /pubmed/37840146 http://dx.doi.org/10.1186/s13287-023-03461-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wen, Wei
Chen, Xiang
Shen, Xin-Yi
Li, Hua-Yu
Zhang, Feng
Fang, Feng-Qi
Zhang, Xiao-Bing
Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis
title Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis
title_full Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis
title_fullStr Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis
title_full_unstemmed Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis
title_short Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis
title_sort enhancing cord blood stem cell-derived nk cell growth and differentiation through hyperosmosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578005/
https://www.ncbi.nlm.nih.gov/pubmed/37840146
http://dx.doi.org/10.1186/s13287-023-03461-x
work_keys_str_mv AT wenwei enhancingcordbloodstemcellderivednkcellgrowthanddifferentiationthroughhyperosmosis
AT chenxiang enhancingcordbloodstemcellderivednkcellgrowthanddifferentiationthroughhyperosmosis
AT shenxinyi enhancingcordbloodstemcellderivednkcellgrowthanddifferentiationthroughhyperosmosis
AT lihuayu enhancingcordbloodstemcellderivednkcellgrowthanddifferentiationthroughhyperosmosis
AT zhangfeng enhancingcordbloodstemcellderivednkcellgrowthanddifferentiationthroughhyperosmosis
AT fangfengqi enhancingcordbloodstemcellderivednkcellgrowthanddifferentiationthroughhyperosmosis
AT zhangxiaobing enhancingcordbloodstemcellderivednkcellgrowthanddifferentiationthroughhyperosmosis